M-M-R II 5000 Ccid50 (Mumps Virus Live Attenuated (Jeryl Lynn Strain) POWDER FOR SOLUTION) 5000 CCID50

M-M-R II 5000 CCID50 is a live attenuated mumps virus vaccine designed for immunization. This powder for solution is administered intramuscularly to help prevent mumps infection.

Strength

5000 CCID50

Pack Size

10X0.5MLVIALS

Manufacturer / TM Owner

MERCK CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

M-M-R II 5000 CCID50 is used for the prevention of mumps, a contagious viral infection. This vaccine is typically administered to individuals who are at risk of exposure to the mumps virus, helping to build immunity and reduce the likelihood of contracting the disease. The vaccine is often recommended as part of routine immunization schedules for children and adults.

Side Effects

Common effects of the M-M-R II 5000 CCID50 vaccine may include mild soreness, redness, or swelling at the injection site. Some individuals may experience temporary fever, fatigue, or mild rash. These effects are generally mild and short-lived, indicating that the body is responding to the vaccine.

Precautions & Warnings

It is important to inform your healthcare provider about any allergies or medical conditions before receiving the M-M-R II 5000 CCID50 vaccine. Individuals with weakened immune systems or those who are pregnant should consult their healthcare provider before vaccination. Always follow the storage and handling instructions provided with the vaccine to ensure its effectiveness.

Avoid Interactions

The M-M-R II 5000 CCID50 vaccine may interact with certain medications, including immunosuppressants and other live vaccines. It is advisable to discuss all current medications with a healthcare provider before receiving this vaccine. Additionally, avoid taking immune-suppressing drugs around the time of vaccination unless directed by a healthcare professional.

Frequently Asked Questions

M-M-R II 5000 CCID50 is used to prevent mumps infection by stimulating the immune system to produce antibodies against the mumps virus.

M-M-R II 5000 CCID50 is administered as an intramuscular injection after reconstituting the powder with the provided diluent.

Common side effects may include mild soreness at the injection site, fever, fatigue, and a mild rash.

Individuals with severe allergies to any component of the vaccine, those with weakened immune systems, and pregnant women should consult a healthcare provider before receiving the vaccine.

It is important to discuss all current medications with a healthcare provider to avoid potential interactions with the M-M-R II 5000 CCID50 vaccine.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.